These interactions reveal the complex mechanisms of miR-193a-5p in cancer development.miR-193a-5p inhibits breast cancer progression by targeting SNHG1 and inactivating the oncogene HOXA1. This evidence concerns the gene HOXA1 and breast carcinoma.